作者:Xing Zheng、Liuying Yu、Jing Yang、Xu Yao、Wenna Yan、Shaowei Bo、Ya Liu、Yun Wei、Zhiyi Wu、Guan Wang
DOI:10.2174/1573406410666140307152557
日期:2014.3.7
A novel series of apigenin derivatives with phloroglucinol or resorcinol as raw materials were synthesized according
to Baker-Venaktaraman reaction and their in vitro inhibitory activities on colorectal adenocarcinoma (HT-29) and
leucocythemia (HL-60) cell lines were evaluated by the standard methyl thiazole tetrazolium (MTT) method. The results
of biological test showed that some of apigenin derivatives possessed stronger anti-cancer activities than apigenin. Compound
6 showed the strongest activity against colorectal adenocarcinoma (HT-29) and leucocythemia (HL-60) cell lines
with IC50 valure of 2.03±0.22 µM, 2.25±0.42 µM, it was better than 5-FU (12.92±0.61 µM, 9.56±0.16 µM), which shows
a potential compound for colorectal adenocarcinoma and leucocythemia.
根据贝克-维纳克塔拉曼反应合成了一系列新型芹菜素衍生物,并以氯代葡萄糖苷醇或间苯二酚为原料,采用标准甲基噻唑四氮唑(MTT)法评价了它们对结直肠腺癌(HT-29)和白血病(HL-60)细胞株的体外抑制活性。生物测试结果表明,一些芹菜素衍生物比芹菜素具有更强的抗癌活性。化合物 6 对结直肠腺癌(HT-29)和白血病(HL-60)细胞株的活性最强,其 IC50 值分别为 2.03±0.22 µM、2.25±0.42 µM,优于 5-FU(12.92±0.61 µM、9.56±0.16 µM),这表明该化合物具有治疗结直肠腺癌和白血病的潜力。